Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Med Sci 2022; 19(14):2080-2086. doi:10.7150/ijms.75820 This issue Cite

Research Paper

Association between serum sphingolipids and necroinflammation of liver tissue pathology in chronic hepatitis B

Yan Ren1,2, Jing Zhao1,2, Manman Xu1,2, Yang Wang1,2, Li Bai1,2, Yingying Jiang1,2, Shuang Liu1,2, Yu Chen1,2, Zhongping Duan1,2, Sujun Zheng1,2✉

1. Liver Disease Center, Beijing YouAn Hospital, Capital Medical University, Beijing China 100069.
2. Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment & Research, Beijing YouAn Hospital, Capital Medical University, Beijing China 100069.

✉ Corresponding author: Prof. Sujun Zheng, Liver Disease Center, Beijing YouAn Hospital, Capital Medical University, No.8 Xitou Tiao Road, Youwai Street, Beijing 100069, China. E-mail: zhengsujunedu.cn, Telephone: +86-10-63291007 Fax: +86-10-632 More

Citation:
Ren Y, Zhao J, Xu M, Wang Y, Bai L, Jiang Y, Liu S, Chen Y, Duan Z, Zheng S. Association between serum sphingolipids and necroinflammation of liver tissue pathology in chronic hepatitis B. Int J Med Sci 2022; 19(14):2080-2086. doi:10.7150/ijms.75820. https://www.medsci.org/v19p2080.htm
Other styles

File import instruction

Abstract

Graphic abstract

Background & Aims: Accurately identifying liver necroinflammation was essential for the timely implementation of antiviral therapy in chronic hepatitis B(CHB) patients. The sphingolipids were involved in various chronic inflammatory processes. This study aimed to evaluate the association between serum sphingolipids and liver necroinflammation in CHB patients.

Methods: The study prospectively enrolled patients with a diagnosis of chronic hepatitis B who were subsequently treated with nucleos(t)ide analogs (NAs). Liver biopsy was performed at baseline and 5-year follow-up, and serum sphingolipid levels were measured by ultra-high-performance liquid chromatography tandem mass spectrometry.

Results: A total of 70 CHB patients were enrolled with baseline liver necroinflammation of 27(38.6%) G1, 23(32.9%) G2, and 20(28.6%) G ≥ 3, respectively. A total of 126 liver biopsies were performed on the study population over a 5-year period, of which 80 (63.5%) G<2 and 46 (36.5%) G≥2. Serum ALT, ALP, SM d16:0/16:1, SM d16:0/17:1, SM d18:0/17:0 and Cer d18:2/22:0 showed significant differences between two groups (P<0.01). Multivariate analysis showed that serum ALT (OR 1.006, 95% CI: 1.000-1.011), SM d16:0/16:1 (OR 1.552, 95% CI: 1.150-2.093), Cer d18:2/22:0 (OR 0.003, 95% CI: 0.000-0.173) were associated with G ≥ 2. In the subgroup of patients with normal serum ALT, serum Cer d18:2/22:0 was lower in patients with G ≥ 2 than that with G < 2. After 5 years, alleviated inflammation was accompanied by decreased serum SM d16:0/16:1 and increased serum Cer d18:2/22:0 in patients with baseline G ≥ 2.

Conclusions: Lower serum Cer d18:2/22:0 could reflect hepatic necroinflammation (G ≥ 2) in CHB patients including those with normal serum ALT, and its elevation predicts the inflammation improvement after NAs treatment.

Keywords: sphingolipid, Ceramide, liver necroinflammation, chronic hepatitis B

Citation styles

APA
Ren, Y., Zhao, J., Xu, M., Wang, Y., Bai, L., Jiang, Y., Liu, S., Chen, Y., Duan, Z., Zheng, S. (2022). Association between serum sphingolipids and necroinflammation of liver tissue pathology in chronic hepatitis B. International Journal of Medical Sciences, 19(14), 2080-2086. https://doi.org/10.7150/ijms.75820.

ACS
Ren, Y.; Zhao, J.; Xu, M.; Wang, Y.; Bai, L.; Jiang, Y.; Liu, S.; Chen, Y.; Duan, Z.; Zheng, S. Association between serum sphingolipids and necroinflammation of liver tissue pathology in chronic hepatitis B. Int. J. Med. Sci. 2022, 19 (14), 2080-2086. DOI: 10.7150/ijms.75820.

NLM
Ren Y, Zhao J, Xu M, Wang Y, Bai L, Jiang Y, Liu S, Chen Y, Duan Z, Zheng S. Association between serum sphingolipids and necroinflammation of liver tissue pathology in chronic hepatitis B. Int J Med Sci 2022; 19(14):2080-2086. doi:10.7150/ijms.75820. https://www.medsci.org/v19p2080.htm

CSE
Ren Y, Zhao J, Xu M, Wang Y, Bai L, Jiang Y, Liu S, Chen Y, Duan Z, Zheng S. 2022. Association between serum sphingolipids and necroinflammation of liver tissue pathology in chronic hepatitis B. Int J Med Sci. 19(14):2080-2086.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use